Published online Nov 26, 2013. doi: 10.13105/wjma.v1.i3.138
Revised: June 13, 2013
Accepted: August 4, 2013
Published online: November 26, 2013
Processing time: 248 Days and 23.4 Hours
AIM: To evaluate the association between apolipoprotein E (apoE) gene polymorphism and total cholesterol (TC) level in patients with kidney diseases.
METHODS: A predefined literature search was performed to collect data from the electronic databases of PubMed, Embase and the Cochrane Library and eligible relevant studies reporting the association of apoE gene polymorphism with TC level in patients with kidney diseases were recruited for meta-analysis.
RESULTS: Twenty-one studies were identified for the analysis of association between apoE gene polymorphism and TC level in patients with kidney disease. Subjects with E3E4 had a higher TC than those with E3E3 [weighted mean differences (WMD) = 2.14, P = 0.01] and subjects with E2E3 had a lower TC than those with E3E3 (WMD = -1.93, P = 0.01). Subjects with ε2 had a lower TC than those with ε3 (ε2 vs ε3: WMD = -1.23, P = 0.002; ε2 vs ε4: WMD = -2.77, P ﹤0.0001) and subjects with 3 had a lower TC than those with 4 (WMD = -0.79, P = 0.03).
CONCLUSION: Subjects with apoE E3E4 and ε4 had a higher TC level and subjects with apoE E2E3 and ε2 had a higher TC level in patients with kidney disease. However, more well-designed studies should be performed in the future to confirm these findings.
Core tip: The available evidence for an association between apolipoprotein E (apoE) and total cholesterol (TC) in kidney disease is weak and has conflicting results. This meta-analysis based on 21 included studies indicated that subjects with apoE E3E4 and 4 had a higher TC level and subjects with apoE E2E3 and ε2 had a higher TC level in patients with kidney disease.